EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease

Meenakshi Sambharia, Prerna Rastogi iD, Christie P Thomas iD

American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2022-09 · 190 (3) · 377-398

DOI: 10.1002/ajmg.c.31990 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, online erschienen am 27.07.2022. Verfasst von Meenakshi Sambharia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Glomerulosclerosis, Focal Segmental, Podocytes, Nephrotic Syndrome. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Focal segmental glomerulosclerosis (FSGS) is not a disease, rather a pattern of histological injury occurring from a variety of causes. The exact pathogenesis has yet to be fully elucidated but is likely varied based on the type of injury and the primary target of that injury. However, the approach to treatment is often based on the degree of podocyte foot process effacement and clinical presentation without sufficient attention paid to etiology. In this regard, there are many monogenic causes of FSGS with variable presentation from nephrotic syndrome with histological features of primary podocytopathy to more modest degrees of proteinuria with limited evidence of podocyte foot process injury. It is likely that genetic causes are largely underdiagnosed, as the role and the timing of genetic testing in FSGS is not established and genetic counseling, testing options, and interpretation of genotype in the context of phenotype may be outside the scope of practice for both nephrologists and geneticists. Yet most clinicians believe that a genetic diagnosis can lead to targeted therapy, limit the use of high‐dose corticosteroids as a therapeutic trial, and allow the prediction of the natural history and risk for recurrence in the transplanted kidney. In this manuscript, we emphasize that genetic FSGS is not monolithic in its presentation, opine on the importance of genetic testing and provide an algorithmic approach to deployment of genetic testing in a timely fashion when faced with a patient with FSGS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulosclerosis, Focal SegmentalPodocytesNephrotic SyndromeHumansKidney

Stichwörter der Autor:innen

Mendelian diseasealbuminuriafoot process effacementgenetic variantnephrotic syndromepodocytopathyproteinuria

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.
  • Department of Pathology, University of Iowa, Iowa City, Iowa, USA.
  • Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA.
  • The Iowa Institute of Human Genetics, University of Iowa, Iowa City, Iowa, USA.
  • Medical Service, Veterans Affairs Medical Center, Iowa City, Iowa, USA.

ORCID-Profile: Prerna Rastogi, Christie P Thomas

Zitieren

APA

Sambharia, M., Rastogi, P., & Thomas, C. P. (2022). Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 190(3), 377-398. https://doi.org/10.1002/ajmg.c.31990

Vancouver

Sambharia M, Rastogi P, Thomas CP. Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2022;190(3):377-398. doi:10.1002/ajmg.c.31990

BibTeX
@article{Sambharia2022,
  author = {Sambharia, Meenakshi and Rastogi, Prerna and Thomas, Christie P},
  title = {Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease},
  journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
  year = {2022},
  volume = {190},
  number = {3},
  pages = {377--398},
  doi = {10.1002/ajmg.c.31990}
}
Kostenlos starten →